Jan 12, 2021 / 09:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan. I'm very pleased to be introducing AbbVie today as we wrap up day 2 of the JPMorgan Healthcare Conference. From AbbVie, we have Rick Gonzalez, Chairman and CEO, making some prepared remarks, and then we'll open up to a broader segment of the management team for Q&A.
Just a reminder before I turn it over to Rick. Anyone who wants to ask a question, feel free to submit those through the Ask-a-Question button on your screen, and I'll integrate those into the Q&A as we go.
With that, let me turn it over to Rick for some prepared remarks.
Richard A. Gonzalez - AbbVie Inc. - Chairman & CEO
All right. Thank you, Chris, and good afternoon to everyone, and certainly it's a pleasure on behalf of AbbVie, for us to be here this afternoon.
I'd like to remind everyone to take a moment to review our forward-looking statement, which is on Slide 2.
Turning to Slide 3. As many of you
Abbvie Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot